Dr Reddy’s Laboratories has won contracts for supply of seven active pharmaceutical ingredients (APIs) to Germany. Out of the 44 bids for the over $3.5 billion sick fund tender in Germany, whose results were declared, Dr Reddy’s won seven bids. Dr Reddy’s had bid for 33 drugs, according to sources in the company.
The tender, the first Europe-wide tender by Germany’s largest health insurance fund Allgemeine Ortskrankenkasse (AOK), is for generic procurement contracts for 64 APIs. The Hyderabad-based pharma major had put in its bid for 48 out of the 64 generic APIs. It is still in the race for the balance 20 bids, with 15 of its own.
The timeline for the supply of the APIs to the five regions of Germany, for which the company has won contracts, will begin in March 2009 and has to be completed in two years. The development is important for Betapharm, Dr Reddy’s subsidiary, which has been struggling in recent times.crackcrack| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1670.60 |
| Dr. Reddys Lab | 1220.90 |
| Cipla | 1231.05 |
| Zydus Lifesciences | 927.40 |
| Lupin | 2324.30 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: